Intravenous Paracetamol, Dexketoprofen and Ibuprofen in the Treatment of Acute Migraine Attack Headache

• Status: Active, not recruiting
• Trial end date: 2020-12-29
• Target enrollment: 0
• Participant gender: All

Summary

• Currently, paracetamol and nonsteroidal antiinflammatory drugs are widely used by emergency physicians in Turkey for the treatment of patients with Acute Migraine Attack Headache

• The objective of the study is compare the efficacy of intravenous dexketoprofen,ibuprofen with paracetamol in the treatment of acute Migraine Attack Headache

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Pamukkale University
• Treatments: Acetaminophen; Dexketoprofen trometamol; Ibuprofen

Criteria

Inclusion Criteria:

• Patients were eligible for inclusion if they were aged 18 years or older, 65 years or younger

• Isolated Migraine Attack Headache

• Patients who agree to work and receive the approval

• VAS (visual analog scale) score>5.

Exclusion Criteria:

• Patients with severe liver, kidney,pulmonary and cardiac heartfailure

• To be Pregnancy and breast-feeding

• Have received analgesics in the last 6hours

• Patients of childbearing age who are not using a birth control method.

• Patients with neurological deficits

• Patients with cardiac chest pain

• Patients with chronic pain

• Patients with pre-existing ibuprofen, dexketoprofen and paracetamol-induced gastrointestinal bleeding and perforation

• Patients with reflected pain

• Patients with neoplastic pain

• Patients with an allergy trait (ibuprofen, paracetamol and dexketoprofen)

• Illiterates and patients with vision problems